Holders over time
- NTRA
- TMO
| Quarter | NTRA | TMO |
|---|---|---|
| Q4 2020 | 15 holders, $741m | 33 holders, $39.2bn |
| Q1 2021 | 17 holders, $911m | 35 holders, $36.5bn |
| Q2 2021 | 20 holders, $1.4bn | 33 holders, $38.3bn |
| Q3 2021 | 17 holders, $1.3bn | 32 holders, $42.6bn |
| Q4 2021 | 14 holders, $1.2bn | 38 holders, $50.1bn |
| Q1 2022 | 13 holders, $551m | 32 holders, $43.2bn |
| Q2 2022 | 14 holders, $473m | 33 holders, $38.9bn |
| Q3 2022 | 10 holders, $365m | 26 holders, $34.3bn |
| Q4 2022 | 12 holders, $266m | 29 holders, $37.0bn |
| Q1 2023 | 14 holders, $658m | 35 holders, $37.1bn |
| Q2 2023 | 10 holders, $474m | 39 holders, $33.5bn |
| Q3 2023 | 10 holders, $554m | 39 holders, $32.6bn |
| Q4 2023 | 12 holders, $695m | 41 holders, $32.7bn |
| Q1 2024 | 18 holders, $2.0bn | 30 holders, $34.1bn |
| Q2 2024 | 22 holders, $2.5bn | 38 holders, $30.6bn |
| Q3 2024 | 25 holders, $3.6bn | 30 holders, $33.8bn |
| Q4 2024 | 28 holders, $4.5bn | 36 holders, $27.6bn |
| Q1 2025 | 21 holders, $4.6bn | 31 holders, $24.2bn |
| Q2 2025 | 21 holders, $5.4bn | 39 holders, $18.8bn |
| Q3 2025 | 23 holders, $4.8bn | 32 holders, $21.9bn |
| Q4 2025 | 26 holders, $8.1bn | 32 holders, $29.9bn |
| Q1 2026 | 20 holders, $6.7bn | 34 holders, $24.4bn |
| Q2 2026 | 23 holders, $10.0bn | 36 holders, $26.4bn |
| Q3 2026 | 22 holders, $16.9bn | 35 holders, $40.3bn |
Natera Inc
- Holders
- 20
- Reported value
- $6.7bn
- Buyers
- 15
- Sellers
- 20
Breadth -5 among 91 comparable managers.
Thermo Fisher Scientific Inc
- Holders
- 34
- Reported value
- $24.4bn
- Buyers
- 23
- Sellers
- 23
Breadth 0 among 91 comparable managers.
Who holds both, Q1 2026
Both (12)
Arrowstreet Capital LP, Artisan Partners LP, Bridgewater Associates LP, Capital World Investors, D. E. Shaw & Co., Farallon Capital Management LLC, Man Group PLC, MFS Investment Management, Point72 Asset Management LP, Renaissance Technologies LLC, T. Rowe Price Associates Inc, Wellington Management Group LLP
Only NTRA (8)
AQR Capital Management LLC, ARK Investment Management LLC, Brevan Howard Capital Management LP, Coatue Management LLC, Maverick Capital Ltd, Polen Capital Management LLC, Rokos Capital Management LLP, Tudor Investment Corp
Only TMO (22)
AllianceBernstein LP, Baillie Gifford & Co, Balyasny Asset Management LLC, Capital Research Global Investors, Citadel Advisors LLC, D1 Capital Partners LP, Dodge & Cox, Fidelity (FMR LLC), GAMCO Investors Inc, Glenview Capital Management LLC, Holocene Advisors LP, Invesco Ltd, Janus Henderson Group Ltd, Markel Group Inc, Marshall Wace LLP, Neuberger Berman Group LLC, Squarepoint Ops LLC, Two Sigma Investments LP, Verition Fund Management LLC, Viking Global Investors LP, Walleye Capital LLC, Woodline Partners LP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.